Arie Goldlust, Ph.D. | Chief Executive Officer, R&DDr. Arie Goldlust has over 25 years of R&D experience in the medical device, biotechnology and pharmaceutical industries.
Prior to founding Datum Biotech, Dr. Goldlust served for 10 years at ColBar LifeScience, a J&J subsidiary, where he served at different capacities with gradual increase responsibilities. In his last capacity as VP Technology and R&D, Arie led the company's development of two worldwide commercialized collagen based products. He managed all R&D activities supporting the regulatory, clinical, manufacturing, quality and marketing development of those products. He also developed a range of novel tissue engineering scaffolds and led collaborations with different J&J research units in a variety of other biomaterial projects.
Prior to joining Colbar, Arie was Manager of Process Development and Protein Research at CBD Technologies, Ltd and before that, he held a research position at the Department of Process Development of Biotechnology General.
Dr. Goldlust received his Ph.D and M.Sc. degrees in biochemistry from the Weizmann Institute of Science, Rehovot, Israel and his B.Sc. degree from the Hebrew University of Jerusalem.. He completed his post‐doctoral training at the Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan USA and at the Department of Biotechnology, Parke‐Davis Pharmaceutical‐Research Division of Warner‐Lambert Company, Ann Arbor, Michigan USA.
Yuval Zubery D.M.D. | Chief Medical OfficerDr. Yuval Zubery has over 25 years of experience in dentistry and periodontics.
Since 1995, Dr. Zubery has had his own private practice specializing in periodontics and dental implants. Author of over 30 publications, he lectures on periodontics, regeneration and dental implantology at international events.
Dr Zubery was voted one of the top 10 dental professionals by Forbes Magazine (Israel) in 2015 and 2016.
Dr. Zubery received his D.M.D. degree in 1984 and his specialty certificate in Periodontics in 1988 from the Dental School of the Hebrew University in Jerusalem. Yuval was lecturer in the Section of Periodontics, School of Dental Medicine, Tel-Aviv University, Israel from 1988 until 1995. He was visiting Assistant Professor in the Department of Periodontics, University of Texas, Health Science Center in San Antonio, Texas U.S.A. in 1991-1992.
Itay Itzhaky | Chairman of the BoardMr. Itay Itzhaky has over 25 years of managerial and entrepreneurial experience in the pharmaceutical and healthcare industries in Israel.
Prior to Datum Dental, Mr. Itzhaky served as CEO of NiTi Surgical Solutions during 2007-2012,, leading the company in development of Nitinol-based disruptive medical devices. Prior to NiTi, Mr. Itzhaky was CEO of ColBar, a biomaterials company (acquired by Johnson & Johnson). Before Colbar, Itay spent 7 years at Teva Pharmaceutical Industries in senior operational positions, managing generic and innovative drug-development operations. Itay was VP Business Development at Promedico, the largest drug importer in Israel (representing Novartis, Pfizer, Abbott etc.). In this capacity, he founded and managed start-up subsidiaries in the medical device and pharmaceutical fields. Prior to these positions, Mr. Itzhaky served as CEO of Eldan Electronic instruments, representing medical device and life science companies such as Hewlett-Packard (Agilent), Amersham Pharmacia Biotech etc.
Mr. Itzhaky holds a B.Sc. in Industrial Engineering from Ben-Gurion University of the Negev, Beer-Sheba, Israel and an MBA from Bar Ilan University, Ramat Gan, Israel.
Thomas Bayer | Director, Research & DevelopmentDr. Thomas Bayer is one of Israel's foremost experts in collagen-derived biomaterials and medical devices.
Prior to joining Datum Dental, Thomas served as R&D Director and Consultant at LifeBond and led the innovative product research group at ColBar LifeSciences Ltd., then a subsidiary of Johnson & Johnson (J&J). In that capacity, he developed a range of novel products including dermal implants, tissue engineering scaffolds, and composite materials. He also worked closely with J&J research staff to support a variety of other biomaterial projects. Previously, Thomas worked as an R&D Project Manager at Teva Pharmaceuticals after completing his post-doctoral research fellowship at Bar Ilan University.
Dr. Bayer holds a doctorate in Chemistry from the TU Dresden, and a M.Sc. in Analytical Chemistry from the TU Bergakademie Freiberg in cooperation with the Leibniz Institute of Polymer Research Dresden.
Edo Eick | Director, Plant & OperationsMr. Eick has over 15 years of expertise in commercial operations in the biotechnology industry, including experience in the manufacturing chain supply operation, facilities and scale-up of production process, product quality assurance (QA) and validation, projects financing and operation budget control and managing.
Prior to joining Datum Dental, Mr. Eick served as a finance auditor at PWC Israel, and as production manager and supply chain manager at Colbar LifeScience Ltd., a biomaterial company focused upon innovative aesthetics and dentistry materials.
Mr. Eick received his B.Sc. in Biotechnology from the Technicon Israel Institue of Technology, and an M.B.A in business administration from the Ban-Gurion University of the Negev. Mr. Eick is also a certificate public accountant.
Yafit Keret | CFOMs. Yafit Keret has over 13 years of experience in the business and financial management of hi-tech and clean-tech companies.
Her expertise includes both financial operation of parent companies as well as establishment and management of subsidiaries located abroad. Yafit has extensive knowledge in founding companies, exit procedures, fundraising, and business development. Her work includes daily financial management which consists of, but is not limited to, auditing, preparation of financial reports, issues concerning tax aspects, as well as active participation in board meetings.
Ms. Keret holds an MBA, Business & Finance and BA and CPA certification, Accounting and Business Administration from The College of Management Academic Studies.
Ellen Fischl Bodner | Director of MarketingEllen has over 20 years of experience in bringing innovative and disruptive technologies to global mainstream adoption. She has held key positions in product marketing, content strategy, clinical and digital marketing and training for med tech (Given Imaging, Lumenis, Mazor Robotics, novoGI) and cyber/high tech (Tufin, Elbit Systems). She is also a pro bono lecturer, including at Technion's BizTec Entrepreneurship Program.
Ellen holds a B.A. summa cum laude from Rutgers University (US) and an M.Sc. in Technical Communications cum laude from Rensselaer Polytechnic Institute (US).
Orit Tal | Director, Regulatory AffairsMs. Orit Tal has over 20 years of experience in regulatory strategy and management of medical device regulatory processes, including market introduction of bio-material based products.
Consecutively to her position at Datum Dental, Ms. Tal serves as VP Regulatory Affairs at LifeBond. Prior to these positions, Orit served as VP of regulatory affairs at ColBar Life Science (acquired by Johnson and Johnson) and at Regentis Biomaterials.
Ms. Tal holds a M.Sc. in Microbiology from the Faculty of Agriculture from the Hebrew University of Jerusalem.
Jeffrey Davis | Director, Quality ControlMr. Jeffrey Davis is a seasoned professional with extensive technical and management experience in the pharmaceutical and medical device industries in South Africa, Canada and Israel.
Jeffrey joined Datum Dental to development and manage the quality systems including for the Company’s manufacturing and research and development departments. Consecutively, he continues to provide consulting services for the development, management and auditing of quality management systems for the medical device industry.
Mr. Davis holds a B.Pharm, Pharmaceutical Sciences from Rhodes University, South Africa and is a licensed pharmacist in Israel.
Daniel Levitats | VP Sales & MarketingMr. Levitats has over 19 years of managerial experience from publically traded global hi-tech and medical device companies. Mr. Levitats has a broad track record of leading business transformation across multiple domains (Sales, Services, Product, Back Office), as well as supporting sales/revenue expansion through direct and business partner channels.
Prior to joining Datum Dental, Mr. Levitats served as VP Sales Operations & eCommerce at Syneron-Candela (a leading Aesthetic Medical Device company). Before Syneron-Candela, Mr. Levitats was Director of Business Process Change at NICE Systems ($1B Software Company), driving cross-company process improvement mostly in Sales and Quote-to-Cash processes. Mr. Levitats held several roles at Mercury Interactive (acquired by HP), leading new product introduction, pricing, and sales force automation.
Mr. Levitats holds a B.Sc. in Industrial & Management Engineering from Ben-Gurion University of the Negev, Beer-Sheba, Israel, and an Executive MBA in Integrative Management from the Hebrew University, Jerusalem, Israel.
Tal Moyal | Director of Sales Operations, Biz Dev & Product Management
Tal has over 15 years of experience managing international sales and building strong business partnerships, product pipelines and customer relations. Her specialties include: strategic planning and execution, pricing/licensing, product launches, project management, business continuity planning, formulating sales teams, business process transformation, sales pipeline/forecasting management and sales enablement. Tal brings rich experience in global companies offering surgical solutions for implant dentistry and prosthetics (Maxillent, Alpha Bio).
Tal holds a B.A. cum laude in Accounting and Financial Management and an MBA in Financial Management from Manchester University.